Objective
Neuroimmune interactions between the sympathetic nervous system (SNS) and macrophages are required for the homeostasis of multiple tissues, including the adipose tissue. It has been proposed that the SNS maintains adipose tissue macrophages (ATMs) in an anti-inflammatory state via direct norepinephrine (NE) signaling to macrophages. This study aimed to investigate the physiological importance of this paradigm by utilizing a mouse model in which the adrenergic signaling from the SNS to macrophages, but not to other adipose tissue cells, was disrupted.
Methods
We generated a macrophage-specific B2AR knockout mouse (
Adrb2
ΔLyz2
) by crossing
Adrb2
fl/fl
and
Lyz2
Cre/+
mice. We have previously shown that macrophages isolated from
Adrb2
ΔLyz2
animals do not respond to NE stimulation
in vitro
. Herein we performed a metabolic phenotyping of
Adrb2
ΔLyz2
mice on either chow or high-fat diet (HFD). We also assessed the adipose tissue function of
Adrb2
ΔLyz2
animals during fasting and cold exposure. Finally, we transplanted
Adrb2
ΔLyz2
bone marrow to low-density lipoprotein receptor (LDLR) knockout mice and investigated the development of atherosclerosis during Western diet feeding.
Results
We demonstrated that SNS-associated ATMs have a transcriptional profile indicative of activated beta-2 adrenergic receptor (B2AR), the main adrenergic receptor isoform in myeloid cells. However,
Adrb2
ΔLyz2
mice have unaltered energy balance on a chow or HFD. Furthermore,
Adrb2
ΔLyz2
mice show similar levels of adipose tissue inflammation and function during feeding, fasting, or cold exposure, and develop insulin resistance during HFD at the same rate as controls. Finally, macrophage-specific B2AR deletion does not affect the development of atherosclerosis on an LDL receptor-null genetic background.
Conclusions
Overall, our data suggest that the SNS does not directly modulate the phenotype of adipose tissue macrophages in either lean mice or mouse models of cardiometabolic disease. Instead, sympathetic nerve activity exerts an indirect effect on adipose tissue macrophages through the modulation of adipocyte function.